| | Call Details | IMS Health Earnings Conference Call (Q2 2009) Thu,
Jul 23, 2009, 8:00 am Eastern
| | About IMS Health
(NYSE:RX) | Other Calls | | IMS Health Incorporated provides business intelligence, including information, analytics, and consulting services to the pharmaceutical and healthcare industries worldwide. The company offers sales territory reporting, prescription tracking reporting, and sales and account management; pharmaceutical audits, medical audits, prescription audits, hospital audits, and published audit reports, as well as analysis of anonymized prescription and/or medical records. It also provides MIDAS, an online multinational integrated data analysis tool to assess and analyze global pharmaceutical information and trends in multiple markets; other portfolio optimization reports; and promotional audits and promotion management consulting, pricing and market access consulting, oncology analyzer and consulting, and forecasting portfolio services. In addition, IMS Health offers products and services, including information to know the effects of managed markets on the pharmaceutical and healthcare industries; information of product movement, market share, and pricing in the consumer health area; and consulting and services, such as evidence-based solutions that allow its clients to make informed business decisions. The company was founded in 1954 and is based in Norwalk, Connecticut. |
| More
Info:
Quote
|
Chart
|
Profile
|
Reports
|
Research
|
SEC
|
Msgs
|
Insider
|
Financials
|
Analyst Ratings |
|